The post Community Banks, Crypto Industry ‘Are Allies’ In CLARITY Act Clash: Exec appeared on BitcoinEthereumNews.com. A crypto executive has pushed back againstThe post Community Banks, Crypto Industry ‘Are Allies’ In CLARITY Act Clash: Exec appeared on BitcoinEthereumNews.com. A crypto executive has pushed back against

Community Banks, Crypto Industry ‘Are Allies’ In CLARITY Act Clash: Exec

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

A crypto executive has pushed back against claims by the president of a community banking association that any compromise between the banking sector and the crypto industry on the US CLARITY Act would be a mistake.

“If community banks and crypto can’t find a way to work together, we already know who the winners are. It’s not the community banks. It’s not consumers. It’s not the crypto industry,” Zero Knowledge Consulting founder Austin Campbell said in an X post on Friday.

“It is the big banks,” Campbell said.

“There is a very straight line between the value community banks bring,” he said, explaining that they face technological and regulatory issues that can be solved by stablecoins.

The major banks “have tricked both sides”

“These are not enemies,” Campbell said of stablecoin-yield providers and community banks, adding that “they are allies.”

“The big banks and the bank lobbies they fund have tricked both sides into fighting each other so that the ultimate winner is Jamie Dimon’s bonus,” he said. 

Source: Patrick Witt

Campbell’s comments came in response to Independent Bankers Association of Texas president Christopher Williston, who said that making concessions in the CLARITY Act debate would risk harming local lending and economic production.

“It’s simply impossible to roll over in the fight for liquidity that powers the economies of the places we call home,” he said.

Banking lobby groups have argued that if the CLARITY Act passes in its current form, stablecoins could siphon deposits from the banking system. Major US bank Standard Chartered recently estimated in a research note that increasing stablecoin adoption could lead to US bank deposits decreasing “by one-third of stablecoin market cap.”

The debate has also drawn comments from the Trump family this week.

Eric Trump, the son of US President Donald Trump, said in a X post on Thursday that large banks are not acting in the best interests of US citizens. “Big Banks (think JPMorgan Chase, Bank of America, Wells Fargo, etc.) are lobbying overtime to block Americans from getting higher yields on their savings.”

Donald Trump urges for the bill “ASAP”

US President Donald Trump also criticized banks for stalling the Senate’s crypto market-structure bill amid ongoing disagreements over stablecoin yield payments.

Related: Revolut makes second attempt at US bank charter, names new CEO for US business

“The U.S. needs to get Market Structure done, ASAP,” Trump said. “The Banks are hitting record profits, and we are not going to allow them to undermine our powerful Crypto Agenda,” he added.

Magazine: The debate over Bitcoin’s four-year cycle is over: Benjamin Cowen

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/crypto-industry-us-clarity-act-community-banks-stablecoin-yields?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09